FDA Investigator: Meisha R. Sampson

- Meisha R. Sampson first started conducting FDA inspections in 2013, with the last inspection in 2024. Over that time, Meisha R. Sampson has conducted 98 inspections at 91 companies across 93 sites.

Get Meisha Sampson's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 MSI Express Inc, Portage | 2024

Out-of-stock
Meisha R. Sampson
Human Drugs Form 483

FDA 483 Frog Prince (China) Daily Chemicals Co.,Ltd, Zhangzhou | 2018

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Guangzhou Hanpu Pharmaceutical Co. Ltd., Guangzhou | 2018

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Suzhou Amerigen Pharmaceutical, Suzhou | 2017

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Nanjing Xingyin Pharmaceutical Group Co. Ltd., Nanjing | 2017

Out-of-stock
Meisha R. Sampson
Animal Drugs & Feed Form 483

FDA 483 Beijing Keyifeng Biotech Development Co., Ltd., Beijing | 2017

Out-of-stock
Meisha R. Sampson
Animal Drugs & Feed Form 483

FDA 483 Antibiotice S.A., Jassi | 2017

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Antibiotice S.A., Lasi | 2017

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 SC Infomed Fluids SRL, Bucharest | 2017

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Relevo, Inc., Carmel | 2016

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Eli Lilly Italia SPA, Sesto Fiorentino | 2016

Out-of-stock
Meisha R. Sampson
Human Drug Form 483

FDA 483 Nice-Pak Products, Inc., Mooresville | 2016

Out-of-stock
Meisha R. Sampson
Human Drug Form 483